Transrectal Prostatic Biopsy in men at risk of variant CJD - Alert to Urological Surgeons

There is a potential risk of vCJD crossinfection during transrectal prostatic biopsy if reusable equipment is employed for this procedure on patients at risk of vCJD, because there is no decontamination method that reliably eliminates or destroys abnormal prion protein This statement from the ACDP TSE Working Group and CJD Incidents Panel provides advice to Urological Surgeons when performing Transrectal Prostatic Biopsy in men at risk of variant CJD